Correlation Between Nordea Bank and Pharma Equity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nordea Bank and Pharma Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nordea Bank and Pharma Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nordea Bank Abp and Pharma Equity Group, you can compare the effects of market volatilities on Nordea Bank and Pharma Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nordea Bank with a short position of Pharma Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nordea Bank and Pharma Equity.

Diversification Opportunities for Nordea Bank and Pharma Equity

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Nordea and Pharma is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Nordea Bank Abp and Pharma Equity Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharma Equity Group and Nordea Bank is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nordea Bank Abp are associated (or correlated) with Pharma Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharma Equity Group has no effect on the direction of Nordea Bank i.e., Nordea Bank and Pharma Equity go up and down completely randomly.

Pair Corralation between Nordea Bank and Pharma Equity

Assuming the 90 days trading horizon Nordea Bank Abp is expected to generate 0.27 times more return on investment than Pharma Equity. However, Nordea Bank Abp is 3.71 times less risky than Pharma Equity. It trades about -0.03 of its potential returns per unit of risk. Pharma Equity Group is currently generating about -0.08 per unit of risk. If you would invest  8,470  in Nordea Bank Abp on September 3, 2024 and sell it today you would lose (482.00) from holding Nordea Bank Abp or give up 5.69% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Nordea Bank Abp  vs.  Pharma Equity Group

 Performance 
       Timeline  
Nordea Bank Abp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Nordea Bank Abp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Nordea Bank is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Pharma Equity Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pharma Equity Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Nordea Bank and Pharma Equity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nordea Bank and Pharma Equity

The main advantage of trading using opposite Nordea Bank and Pharma Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nordea Bank position performs unexpectedly, Pharma Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharma Equity will offset losses from the drop in Pharma Equity's long position.
The idea behind Nordea Bank Abp and Pharma Equity Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.